Simultaneous Radiochemotherapy

Introduction to Simultaneous Radiochemotherapy

• The simultaneous radiochemotherapy is a treatment method where radiation therapy and chemotherapy are administered simultaneously to improve tumor control and increase survival rates, as recommended by the British Journal of Cancer and Annals of Oncology 1, 2

Clinical Applications

• Simultaneous radiochemotherapy has been shown to be effective in various types of tumors, including non-small cell lung cancer stage III, with improved overall survival, according to the Annals of Oncology 2
• The European Society for Medical Oncology recommends simultaneous radiochemotherapy for bladder cancer, with cisplatin as the most commonly used chemotherapeutic agent, as stated in the Journal of the National Comprehensive Cancer Network 4

Benefits over Sequential Therapy

• Simultaneous radiochemotherapy has been shown to be superior to sequential therapy in terms of overall survival, with an absolute improvement of 4.5% after 5 years in non-small cell lung cancer stage III, as reported by the Annals of Oncology 2

Commonly Used Chemotherapeutic Agents

• Cisplatin is the most commonly used and well-studied chemotherapeutic agent for simultaneous radiochemotherapy, according to the Annals of Oncology and British Journal of Cancer 2, 3
• Other commonly used agents include mitomycin C, carboplatin, taxanes, and gemcitabine, as stated in the Journal of the National Comprehensive Cancer Network and British Journal of Cancer 4, 5, 6

Practical Implementation

• For bladder cancer, external beam radiation therapy with 40 Gy is typically administered with concurrent cisplatin in weeks 1 and 4, as recommended by the Journal of the National Comprehensive Cancer Network 6, 7

Future Perspectives

• Newer techniques such as three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and image-guided radiation therapy offer the possibility of increasing the dose in the tumor while sparing healthy tissue, as reported by the British Journal of Cancer 1, 8
• The development of substances that selectively sensitize cancer cells to radiation could further improve the effectiveness of simultaneous radiochemotherapy, according to the British Journal of Cancer 1